| Trial ID: | L2444 |
| Source ID: | NCT02538848
|
| Associated Drug: |
Htd4010
|
| Title: |
Study of HTD4010 in Healthy Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: HTD4010
|
| Outcome Measures: |
Primary: Incidence, severity and causality of adverse events, One day in SAD |
|
| Sponsor/Collaborators: |
Sponsor: HighTide Biopharma Pty Ltd
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-10
|
| Completion Date: |
2016-03
|
| Results First Posted: |
|
| Last Update Posted: |
2020-07-27
|
| Locations: |
Linear Clinical Research Limited, Perth, WA6009, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT02538848
|
